Insider · CIK 0001315797
Satter Muneer A
Reports to the SEC for 9 companies · BRISBANE, CA
Transactions
50
Companies
9
Filings
14
CIK
0001315797
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-11 | ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-05-28 | ANNXAnnexon, Inc.P Purchase | +$3.32M |
| 2025-11-21 | ANNXAnnexon, Inc.P Purchase | +$1.81M |
| 2025-11-20 | ANNXAnnexon, Inc.P Purchase | +$1.79M |
| 2025-11-19 | ANNXAnnexon, Inc.P Purchase | +$1.97M |
| 2025-11-18 | ANNXAnnexon, Inc.P Purchase | +$1.59M |
| 2025-11-17 | ANNXAnnexon, Inc.P Purchase | +$1.5M |
| 2025-06-05 | ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-05 | ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-12-26 | ANNXAnnexon, Inc.P Purchase | +$1.01M |
| 2023-06-08 | ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-02-10 | ANNXAnnexon, Inc.P Purchase | +$18M |
| 2022-07-07 | ANNXAnnexon, Inc.P Purchase | +$9.42M |
| 2022-07-07 | ANNXAnnexon, Inc. · Warrants (Right to Buy)P Purchase | +$76.7K |
| 2022-06-09 | ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-06-02 | ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-01-08 | RNTXRein Therapeutics, Inc.P Purchase | +$9.9M |
| 2020-07-28 | ANNXAnnexon, Inc.C Conversion | — |
| 2020-07-28 | ANNXAnnexon, Inc.P Purchase | +$3.4M |
| 2020-07-28 | ANNXAnnexon, Inc. · Series A-1 Preferred StockC Conversion | — |
| 2020-07-28 | ANNXAnnexon, Inc. · Series B Preferred StockC Conversion | — |
| 2020-07-28 | ANNXAnnexon, Inc. · Series C Preferred StockC Conversion | — |
| 2020-07-28 | ANNXAnnexon, Inc. · Series D Preferred StockC Conversion | — |
| 2020-06-08 | RNTXRein Therapeutics, Inc.P Purchase | +$4.07M |
| 2019-06-18 | WHWKWhitehawk Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-01-10 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$58.4K |
| 2019-01-09 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$47.9K |
| 2019-01-08 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$44K |
| 2019-01-07 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$43.6K |
| 2019-01-04 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$42.4K |
| 2019-01-03 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$41.5K |
| 2019-01-02 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$38.8K |
| 2018-12-31 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$34.9K |
| 2018-12-28 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$34.4K |
| 2018-12-27 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$33.4K |
| 2018-12-26 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$33.9K |
| 2018-12-21 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$36.9K |
| 2018-12-20 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$37K |
| 2018-12-19 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$38.4K |
| 2018-12-18 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$39.9K |
| 2018-12-14 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$40.1K |
| 2018-12-13 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$40.3K |
| 2018-12-12 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$40.9K |
| 2018-12-11 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$41.8K |
| 2018-12-10 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$42.6K |
| 2018-12-07 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$42.8K |
| 2018-12-06 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$43.6K |
| 2018-12-04 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$42K |
| 2018-12-03 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$39.8K |
| 2018-11-30 | WHWKWhitehawk Therapeutics, Inc.P Purchase | +$39.7K |
Recent filings
- 4Satter Muneer A0001315797-26-000002SEC(opens sec.gov)
- 4Satter Muneer A0001315797-26-000001SEC(opens sec.gov)
- 4Satter Muneer A0001315797-25-000007SEC(opens sec.gov)
- 4Satter Muneer A0001315797-25-000006SEC(opens sec.gov)
- 4Satter Muneer A0001415889-25-016267SEC(opens sec.gov)
- 4Satter Muneer A0001415889-24-016106SEC(opens sec.gov)
- 4Satter Muneer A0001209191-23-059911SEC(opens sec.gov)
- 4Satter Muneer A0001610717-23-000152SEC(opens sec.gov)
- 4Satter Muneer A0001567619-23-002932SEC(opens sec.gov)
- 4Satter Muneer A0001567619-22-013890SEC(opens sec.gov)
- 4Satter Muneer A0001567619-22-012779SEC(opens sec.gov)
- 4Satter Muneer A0001567619-21-011723SEC(opens sec.gov)
- 4Satter Muneer A0000899243-21-001163SEC(opens sec.gov)
- 4Satter Muneer A0001567619-20-013817SEC(opens sec.gov)
Companies
- Akebia Therapeutics, Inc.DirectorAKBA
- Annexon, Inc.DirectorANNX
- AxonPrime Infrastructure Acquisition CorpDirector
- DFC GLOBAL CORP.Director
- Eledon Pharmaceuticals, Inc.10% OwnerELDN
- HeartWare International, Inc.10% Owner
- IMMUNIC, INC.Director, 10% OwnerIMUX
- Rein Therapeutics, Inc.Director, See RemarksRNTX
- Whitehawk Therapeutics, Inc.Director, 10% OwnerWHWK
Address
C/O ANNEXON, INC. 1400 SIERRA POINT PKWY, BLDG C, STE 200
BRISBANE, CA, 94005